Zydus Lifesciences
Signals mentioning Zydus Lifesciences
- Lupin flags higher US drug prices and shortage risks from proposed generic-drug tariffs
- IPC to set uniform semaglutide quality standards as Indian generic market expands
- Macquarie backs Zydus as consumer wellness and branded medicines raise growth mix
- India pharma market grows 12.1% in July as Sun Pharma and Zydus outpace sector
- Zydus consumer wellness revenue jumps 67% in Q1 despite 36% profit fall
- Zydus Q1 profit drops 36% as revenue rises 22%; consumer wellness jumps 67%
- Bata India set to report Q1FY27 results for April–June quarter
- MRF Q1 FY27 preview: revenue seen up 12%, but raw-material inflation may squeeze margins
- HDFC Securities sees FY27 consumer recovery, but input volatility clouds margins
- India pharma market grows 16% as drugmakers enter US tariff-free transition
- GTRI flags proposed US generic-drug tariffs as major risk for Indian pharma exporters
- Indian generic drugmakers face potential US tariff shock from 2028
- Indian pharma stocks slide as Trump outlines tariffs of up to 200% on generic drugs
- Nykaa plugs into ChatGPT, opens catalogue to OpenAI-powered discovery
- Zydus Q4 profit up 8.7% to ₹1,272 cr; ₹1,100 cr buyback as consumer wellness jumps 54%
- Amul hikes milk prices Rs 2/litre as Airtel, Zydus unveil major corporate moves ahead of Q4 results
- DCGI orders nationwide crackdown on illegal sildenafil, tadalafil sales across pharmacies and e-platforms